Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Clinical, Cosmetic and Investigational Dermatology|November 6, 2023
JAK Inhibitors in Psoriatic DiseaseMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|June 4, 2024
Risk Factors for Psoriasis Flares: A Narrative ReviewLuca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Minerva Endocrinology|July 29, 2020
Impact of current antipsoriatic systemic treatments on male and female fertility: what endocrinologists need to knowSara Cacciapuoti, Emanuele Scala, Matteo Megna, et al.
Clinical Rheumatology|June 2, 2017
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world studyMaddalena Napolitano, Luisa Costa, Francesco Caso, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical studyMaddalena Napolitano, Nicola Balato, Francesco Caso, et al.
Minerva Endocrinologica|April 29, 2020
Vitamin D and psoriasis: an update for dermatologists and nutritionistsMatteo Megna, Maria Ferrillo, Luigi Barrea, et al.
Expert Opinion on Drug Safety|August 12, 2024
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasisTeresa Battista, Vincenzo Picone, Matteo Noto, et al.
Advances in Therapy|May 6, 2024
Management of Psoriasis Patients with Serious Infectious DiseasesMatteo Megna, Giuseppe Lauletta, Nello Tommasino, et al.
The Journal of Dermatological Treatment|May 23, 2022
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective studyMatteo Megna, Nello Tommasino, Luca Potestio, et al.
Dermatology and Therapy|December 28, 2016
Systemic Treatment of Adult Atopic Dermatitis: A ReviewMatteo Megna, Maddalena Napolitano, Cataldo Patruno, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Clinical, Cosmetic and Investigational Dermatology|November 6, 2023
JAK Inhibitors in Psoriatic DiseaseMatteo Megna, Luca Potestio, Angelo Ruggiero, et al.
Psoriasis (Auckland, N.Z.)|June 4, 2024
Risk Factors for Psoriasis Flares: A Narrative ReviewLuca Potestio, Giuseppe Lauletta, Nello Tommasino, et al.
Minerva Endocrinology|July 29, 2020
Impact of current antipsoriatic systemic treatments on male and female fertility: what endocrinologists need to knowSara Cacciapuoti, Emanuele Scala, Matteo Megna, et al.
Clinical Rheumatology|June 2, 2017
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world studyMaddalena Napolitano, Luisa Costa, Francesco Caso, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical studyMaddalena Napolitano, Nicola Balato, Francesco Caso, et al.
Minerva Endocrinologica|April 29, 2020
Vitamin D and psoriasis: an update for dermatologists and nutritionistsMatteo Megna, Maria Ferrillo, Luigi Barrea, et al.
Expert Opinion on Drug Safety|August 12, 2024
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasisTeresa Battista, Vincenzo Picone, Matteo Noto, et al.
Advances in Therapy|May 6, 2024
Management of Psoriasis Patients with Serious Infectious DiseasesMatteo Megna, Giuseppe Lauletta, Nello Tommasino, et al.
The Journal of Dermatological Treatment|May 23, 2022
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective studyMatteo Megna, Nello Tommasino, Luca Potestio, et al.
Dermatology and Therapy|December 28, 2016
Systemic Treatment of Adult Atopic Dermatitis: A ReviewMatteo Megna, Maddalena Napolitano, Cataldo Patruno, et al.
Pageof 26